인후두 역류증의 미세구조 및 분자 수준의 특성

참고문헌 (74)

1. Koufman JA, "Reflux laryngitis and its sequelae: The diagnostic role of ambulatory 24-hour pH monitoring", J Voice, 2(1), pp.78~89 (1988)
2. Koufman JA, "Laryngopharyngeal reflux: a new paradigm of airway disease", Ear Nose Throat J, 81(9), pp.2~6 (2002)
3. Rees LEN, "The mucosal immune response to laryngopharyngeal reflux", Am J Respir Crit Care Med, 177(11), pp.1187~1193 (2008)
4. Koufman JA, "The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): A clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury", Laryngoscope, 101(4), pp.1~64 (1991)
5. Calabrese C, "intercellular spaces as a marker of oesophageal damage: Comparative results in gastro oesophageal reflux disease with or without bile reflux", Alimnt Pharmacol Ther, 18(5), pp.525~532 (2003)
6. Carney DN, "Morphologic alterations in early acid-induced epithelial injury of the rabbit esophagus", Lab Invest, 45(2), pp.198~208 (1981)
7. Caviglia R, "Dilatated intercellular space of esophageal epithelium in nonerosive relux disease patients with physiological esophageal acid exposure", Am J Gastroenterol, 100(3), pp.543~548 (2005)
8. Hopwood D, "Electron microscopic changes in human oesophageal epithelium in oesophagitis", J Pathol, 129(4), pp.161~167 (1979)
9. Tobey N, "Dilated intercellular spaces: A morphological feature of acid reflux-damaged human esophageal epithelium", Gastroenterology, 111(5), pp.1200~1205 (1996)
10. Adhami T, "The role of gastric and duodenal agents in laryngeal injury: an experimental canine model", Am J Gastroenterol, 99(11), pp.2098~2106 (2004)
11. Cohen SM, "Acute histologic effects of extraesophageal reflux on vocal fold healing", Ann Otol Rhinol Laryngol, 114(4), pp.296~303 (2005)
12. Maronian N, "Histologic features of reflux-attributed laryngeal lesions", Am J Med, 115(3), pp.105~108 (2003)
13. Johnston N, "Cell biology of laryngeal epithelial defenses in health and disease: further studies", Ann Otol Rhinol Laryngol, 112(6), pp.481~491 (2003)
14. Franchi A, "Dilatation of intercellular space is associated with laryngopharyngeal reflux: An ultrastructural morphometric analysis of laryngeal epithelium", Eur Arch Otorhinolaryngol, 264(8), pp.907~911 (2007)
15. Lanas A, "Experimental esophagitis induced by acid and pepsin in rabbits mimicking human reflux esophagitis", Gastroenterology, 116(1), pp.97~107 (1999)
16. Tobey NA, "The role of pepsin in acid injury to esophageal epithelium", Am J Gastroenterol, 96(11), pp.3026~3070 (2001)
17. Tobey NA, "HCl-induced cell edema in primary cultured rabbit esophageal epithelium", Gastroenterology, 112(3), pp.847~854 (1997)
18. Lanas AI, "Aspirin renders the oesophageal mucosa more permeable to acid and pepsin", Eur J Gastroenterol Hepatol, 7(11), pp.1065~1072 (1995)
19. Schweitzer EJ, "Sucralfate prevents experimental esophagitis in rabbits", Gastroenterology, 88(3), pp.611~619 (1985)
20. Tay HP, "Bismuth subsalicylate reduces peptic injury of the esophagus in rabbits", Gut, 31(1), pp.11~16 (1990)
21. Hopwood D, "Oesophageal damage and defense in reflux oesophagitis: Pathophysiological and cell biological mechanisms", Prog Histochem Cytochem, 32(3), pp.1~42 (1997)
22. Orlando RC, "Gastroesophageal reflux disease: Offensive factors and tissue resistance" (2000), Dekker
23. Goldstein JL, "The esophageal mucosal resistance: Structure and function of an unique gastrointestinal epithelial barier", J Lab Clin Med, 123(5), pp.653~659 (1994)
24. Orlando RC, "Esophageal epithelial defense against acid injury", Am J Gastroenterol, 89(8), pp.48~52 (1994)
25. Salo JA, "Morphological alterations in experimental esophagitis: Light microscopic and scanning and transmission electron microscopic study", Dig Dis Sci, 28(5), pp.440~448 (1983)
26. Shimono M, "Intercellular junctions of oral epithelium II: Ultrastructural changes in rat buccal epithelium induced by trpsin digestion", J Ultrastruct Res, 59(1), pp.101~112 (1977)
27. Postma GN, "Esophageal motor function in laryngopharyngeal reflux is superior to that in classic gastroesophageal reflux disease", Ann Otol Rhinol Laryngol, 110(12), pp.1114~1116 (2001)
28. Bell NJ, "Role of gastric acind suppression in the treatment of gastro-oesophageal reflux disease", Gut, 33(11), pp.118~124 (1992)
29. Bremner RM, "Concentration of refluxed acid and esophageal mucosal injury", Am J Surg, 164(5), pp.552~526 (1992)
30. Farrow DC, "Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer", 2000, 11(3), pp.231~238 (2000)
31. Gill GA, "Characterisation of adherens and tight junctional molecules in normal animal larynx: Determining a suitable model for studying molecular abnormalities in human laryngopharyngeal reflux", J Clin Pathol, 58(12), pp.1265~1270 (2005)
32. Reichel O, "E-cadherin but not β-catenin expression is decreased in laryngeal biopsies from patients with laryngopharyngeal reflux", Eur Arch Otorhinolaryngol, 265(8), pp.937~942 (2008)
33. Christie KN, "Carbonic anhydrase isoenzymes I, II, III, and IV are present in human esophageal epithelium", J Histochem Cytochem, 45(1), pp.35~40 (1997)
34. Tashian RE, "The carbonic anhydrase: widening perspectives on their evolution, expression and function", Bioassays, 10(6), pp.186~192 (1989)
35. Sly WS, "Human carbonic anhydrases and carbonic anhydrase deficiencies", Annu Rev Biochem, (64), pp.375~401 (1995)
36. Parkkila S, "Carbonic anhydrase in the aloimentary tract; roles of the different isoenzymes and salivary factors in the maintenance of optimal conditions in the gastrointestinal canal", Scand J Gastroenterol, 31(4), pp.305~317 (1996)
37. Tobey NA, "Serosal bicarbonate protects against acid injury to rabbit esophagus", Gastroenterology, 96(6), pp.1466~1477 (1989)
38. Helm JF, "Acid neutralizing capacity of human saliva", Gastroenterology, 83(1), pp.69~74 (1982)
39. Axford SE, "Cell biology of laryngeal epithelial defenses in health and disease: Preliminary studies", Ann Otol Rhinol Laryngol, 110(12), pp.1099~1108 (2001)
40. Gill GA, "Laryngeal epithelial defense against laryngopharyngeal reflux: Investigations of E-cadherin, carbonic anhydrase isoenzyme III, and pepsin", Ann Otol Rhinol Laryngol, 114(10), pp.913~921 (2005)
41. Ylitalo R, "Symptoms, laryngeal findings, and 24-hour pH monitoring in patients with suspected gastroesophagopharyngeal reflux", Laryngoscope, 111(10), pp.1735~1741 (2001)
42. Noordzij JP, "Levine PA. Correlation of pH probe-measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis", Laryngoscope, 112(12), pp.2192~2195 (2002)
43. Powitzky ES, "Symptoms, quality of life, videolaryngoscopy, and twenty-four-hour tripleprobe pH monitoring in patients with typical and extraesophageal reflux", Ann Otol Rhinol l.aryngol, 112(10), pp.859~865 (2003)
44. Hill RK, "Pachydermia is not diagnostic of active laryngopharyngeal reflux disease", Laryngoscope, 114(9), pp.1557~1561 (2004)
45. Vaezi MF, "Treatment of chronic posterior laryngitis with esomeprazole", Laryngoscope, 116(2), pp.254~260 (2006)
46. Steward DL, "Proion pump inhibitor therapy for chronic laryngopharyngitis: A randomized placebo-control trial", Otolaryngol Head Neck Surg, 131(4), pp.342~350 (2004)
47. Sifrim D, "Acid, weakly acidic and non-acid gastro-oesophageal reflux: Differences, prevalence and clinical relevance", Eur J Gastroenterol Hepatol, 16(9), pp.823~830 (2004)
48. Smit CF, "Ambulatory pH measurements at the upper esophageal sphincter", Laryngoscope, 108(2), pp.299~302 (1998)
49. Bove M, "24-H pharyngeal pH monitoring in healthy volunteers: A normative study", Scand J Gastroenterol, 35(3), pp.234~241 (2000)
50. Oelschlager BK, "Gastroesophageal and pharyngeal reflux detection using impedance and 24- hour pH monitoring in asymptomatic subjects: Defining the normal environment", J Gastrointest Surg, 10(1), pp.54~62 (2006)
51. Ulualp SO, "Prevalence of gastroesophageal acid reflux events: An evidence-based systematic review", Am J Otolaryngol, 26(4), pp.239~244 (2005)
52. Ylitalo R, "Relationship between time of exposure of laryngopharyngeal reflux and gene expression in laryngeal fibroblasts", Ann Otol Rhinol Laryngol, 115(10), pp.775~783 (2006)
53. Koufman JA, "Laryngopharyngeal reflux: Position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery", Otolaryngol Head Neck Surg, 127(1), pp.32~35 (2002)
54. Orlando RC, "Pathogenesis of gastroesophageal reflux disease", Am J Med Sci, 326(5), pp.274~278 (2003)
55. Lipan MJ, "Anatomy of reflux: A growing health problem affecting structures of the head and neck", Anat Rec B New Anat, 284(6), pp.274~278 (2006)
56. Kinoshita M, "Role of salivary mucin in the protection of rat esophageal mucosa from acid and pepsin-induced injury", Am J Physiol, 277(4), pp.796~800 (1999)
57. Hollingsworth MA, "Mucins in cancer: Protection and control of the cell surface", Nat Rev Cancer, 4(1), pp.45~60 (2004)
58. Burjonrappa SC, "Mucin expression profile in Barrett’s, dysplasia, adenocarcinoma sequence in the esophagus", Indian J Cancer, 44(1), pp.1~5 (2007)
59. Namiot Z, "Declined human esophageal mucin secretion in patients with severe reflux esophagitis", Dig Dis Sci, 39(12), pp.2523~2529 (1994)
60. Samuels TL, "Mucin gene expression in human laryngeal epithelia: Effect of laryngopharyngeal reflux", Ann Otol Rhinol Laryngol, 117(9), pp.688~695 (2008)
61. Thibeult SL, "Gene expression changes of inflammatory mediators in posterior laryngitis due to laryngopharyngeal reflux and evolution with PPI treatment: A preliminary study", Laryngoscope, 117(11), pp.250~2056 (2007)
62. Eherer AJ, "Effect of pantoprazole on the course of reflux-associated laryngitis: A placebo-controlled bouble-blind crossover study", Scand J Gastroenterol, 38(5), pp.462~467 (2003)
63. Noordzij JP, "Evaluation of omeprozole in the treatment of reflux laryngitis: A prospective, placebo-controlled, randomized, double-blind study", Laryn-goscope, 111(12), pp.2147~2151 (2001)
64. Qadeer MA, "Proton pump inhibitor theapy for suspected GERD-related chronic laryngitis: A meta-analysis of randomized controlle trials", Am J Gastroenterol, 101(11), pp.2646~2656 (2006)
65. Helm JF, "Salivary response to esophageal acid in normal subjects and patients with reflux esophagitis", Gastroenterol, 93(6), pp.1393~1397 (1987)
66. Li L, "Effect of esophageal intraluminal mechanical and chemical stressors on salivary epidermal growth factor in humans", Am J Gastroenterol, 88(10), pp.1749~1755 (1993)
67. Tobey NA, "How does the esophageal epithelium maintain its integrity?", Digestion, 56(1), pp.45~50 (1995)
68. Sarosiek J, "Do salivary organic components play a protective role in health and disease of the esophageal mucosa?", Digestion, 56(1), pp.32~37 (1995)
69. Marcinkiewicz M, "Role of epidermal growth factor (EGF) in oesophageal mucosal integrity", Curr Med Res Opin, 14(3), pp.145~153 (1998)
70. Marcinkiewicz M, "The potential role of the esophageal pre-epithelial barrier components in the maintenance of integrity of the esophageal mucosa in patients with endoscopically negative gastroesophageal reflux disease", Am J Gastroenterol, 95(7), pp.1652~1660 (2000)
71. Eckley CA, "Salivary epidermal growth factor concentration in adults with reflux laryngitis", Otolaryngol Head Neck Surg, 131(4), pp.401~406 (2004)
72. Eckley CA, "Salivary egf concentration in adults with reflux chronic laryngitis before and after treatment: Preliminary results", Rev Bras Otohhinolaringol, 73(2), pp.156~160 (2007)
73. Costa HO, "Is there a correlation between saliva pH and volume and reflux laryngitis?", Dysphagia (2005)
74. Costa HO, "Comparative study of salivary pH and volume in adults with chronic laryngopharyngitis by gastroesophageal reflux disease before and after treatment", Braz J Otorhinolaryngol, 72(1), pp.55~60 (2006)

관련 논문AI추천